Alcon AG
ALC96.625USD
-0.984-1.01%
交易中 （美東）報價延遲15分鐘
47.79B總市值
46.95本益比TTM
關於 Alcon AG 公司
Alcon AG 是一家總部位於瑞士的眼科護理公司。該公司研究、開發、製造、分銷和銷售兩大核心業務領域的全套眼科護理產品：外科和視力護理。該公司的外科業務專注於白內障手術、玻璃體視網膜手術、屈光激光手術和青光眼手術的眼科產品。外科產品組合包括這些手術所需的植入物、耗材和手術設備，並支持眼科醫生的端到端需求。該公司的視力護理業務包括日拋型、可重複使用型和增色型隱形眼鏡以及一系列眼部健康產品，包括用於乾眼症、眼部過敏、青光眼和隱形眼鏡護理的產品，以及眼部維生素和紅腫緩解劑。該公司在 60 個國家開展業務，爲 140 多個國家的消費者和患者提供服務。
公司簡介
公司代碼ALC
公司名稱Alcon AG
上市日期Apr 09, 2019
成立日期2018
CEOMr. David J. Endicott
員工數量25599
證券類型Ordinary Share
年結日Apr 09
公司地址Rue Louis d'Affry 6
城市FRIBOURG
上市交易所SIX Swiss Exchange
國家Switzerland
郵編1701
電話41589112222
網址https://www.alcon.ch/
公司代碼ALC
上市日期Apr 09, 2019
成立日期2018
公司高階主管
名稱
名稱/職務
職務
持股
持股變動
Mr. David J. Endicott
Mr. David J. Endicott
Chief Executive Officer, Director
Chief Executive Officer, Director
207.11K
-11.08%
Mr. Timothy C. (Tim) Stonesifer
Mr. Timothy C. (Tim) Stonesifer
Chief Financial Officer
Chief Financial Officer
134.23K
+38.34%
Mr. Rajkumar Narayanan
Mr. Rajkumar Narayanan
Senior Vice President, President - International
Senior Vice President, President - International
37.83K
+9.30%
Mr. Ian Bell
Mr. Ian Bell
Chief Operating Officer
Chief Operating Officer
30.23K
-24.88%
Ms. Karen J. May, CPA
Ms. Karen J. May, CPA
Independent Director
Independent Director
28.32K
+11.14%
Mr. Laurent Attias
Mr. Laurent Attias
Senior Vice President - Corporate Strategy, Business Development and Licensing (BD&L) and Mergers and Acquisitions (M&A)
Senior Vice President - Corporate Strategy, Business Development and Licensing (BD&L) and Mergers and Acquisitions (M&A)
22.62K
+15.19%
Mr. Scott Harlan Maw
Mr. Scott Harlan Maw
Independent Director
Independent Director
17.26K
+14.57%
Ms. Ines Poeschel
Ms. Ines Poeschel
Independent Director
Independent Director
12.08K
+15.09%
Ms. Lynn Dorsey Bleil
Ms. Lynn Dorsey Bleil
Independent Director
Independent Director
10.94K
+13.26%
Mr. Leon Sergio Duplan Fraustro
Mr. Leon Sergio Duplan Fraustro
Senior Vice President, President - Americas
Senior Vice President, President - Americas
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. David J. Endicott
Mr. David J. Endicott
Chief Executive Officer, Director
Chief Executive Officer, Director
207.11K
-11.08%
Mr. Timothy C. (Tim) Stonesifer
Mr. Timothy C. (Tim) Stonesifer
Chief Financial Officer
Chief Financial Officer
134.23K
+38.34%
Mr. Rajkumar Narayanan
Mr. Rajkumar Narayanan
Senior Vice President, President - International
Senior Vice President, President - International
37.83K
+9.30%
Mr. Ian Bell
Mr. Ian Bell
Chief Operating Officer
Chief Operating Officer
30.23K
-24.88%
Ms. Karen J. May, CPA
Ms. Karen J. May, CPA
Independent Director
Independent Director
28.32K
+11.14%
Mr. Laurent Attias
Mr. Laurent Attias
Senior Vice President - Corporate Strategy, Business Development and Licensing (BD&L) and Mergers and Acquisitions (M&A)
Senior Vice President - Corporate Strategy, Business Development and Licensing (BD&L) and Mergers and Acquisitions (M&A)
22.62K
+15.19%
收入明細
單位: USD更新時間: 4月6日 週日
單位: USD更新時間: 4月6日 週日
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
業務USD
名稱
營收
佔比
Consumables
2.86B
29.09%
Contact lenses
2.61B
26.53%
Implantables
1.77B
18.05%
Ocular health
1.71B
17.33%
Equipment/other
886.00M
9.01%
地區USD
名稱
營收
佔比
United States
4.51B
45.86%
Other
4.13B
42.01%
China
560.00M
5.69%
Japan
554.00M
5.63%
Switzerland
79.00M
0.80%
業務
地區
業務USD
名稱
營收
佔比
Consumables
2.86B
29.09%
Contact lenses
2.61B
26.53%
Implantables
1.77B
18.05%
Ocular health
1.71B
17.33%
Equipment/other
886.00M
9.01%
股東統計
更新時間: 3月13日 週四
更新時間: 3月13日 週四
持股股東
股東類型
持股股東
股東統計
佔比
UBS Asset Management (Switzerland)
5.84%
BlackRock Advisors (UK) Limited
4.94%
The Vanguard Group, Inc.
3.87%
T. Rowe Price Investment Management, Inc.
3.02%
Fidelity Management & Research Company LLC
3.01%
Other
79.32%
持股股東
股東統計
佔比
UBS Asset Management (Switzerland)
5.84%
BlackRock Advisors (UK) Limited
4.94%
The Vanguard Group, Inc.
3.87%
T. Rowe Price Investment Management, Inc.
3.02%
Fidelity Management & Research Company LLC
3.01%
Other
79.32%
股東類型
股東統計
佔比
Investment Advisor
33.93%
Investment Advisor/Hedge Fund
29.79%
Bank and Trust
4.48%
Sovereign Wealth Fund
2.61%
Hedge Fund
2.45%
Pension Fund
1.44%
Research Firm
1.23%
Individual Investor
0.13%
Insurance Company
0.10%
Other
23.84%
機構持股
更新時間: 1月19日 週日
更新時間: 1月19日 週日
報告期間
機構數
持股數
持股佔比
持股變動
2025Q1
1610
381.09M
76.26%
+43.43M
2024Q4
1636
370.45M
74.13%
+31.24M
2024Q3
1624
333.39M
66.72%
-2.12M
2024Q2
1594
337.16M
67.47%
-33.61M
2024Q1
1583
337.34M
67.51%
+4.25M
2023Q4
1598
326.79M
65.39%
-10.87M
2023Q3
1582
325.37M
65.11%
-21.48M
2023Q2
1575
329.22M
65.88%
-15.79M
2023Q1
1566
324.92M
65.02%
+2.70M
2022Q4
1564
305.91M
61.22%
-40.51M
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
UBS Asset Management (Switzerland)
29.21M
5.84%
+29.21M
--
Dec 31, 2024
BlackRock Advisors (UK) Limited
24.68M
4.94%
--
--
Dec 31, 2024
The Vanguard Group, Inc.
19.35M
3.87%
+211.11K
+1.10%
Dec 31, 2024
T. Rowe Price Investment Management, Inc.
15.08M
3.02%
+8.71M
+136.76%
Feb 03, 2025
Fidelity Management & Research Company LLC
12.09M
2.42%
+611.30K
+5.32%
Dec 31, 2024
Aristotle Capital Management, LLC
12.83M
2.57%
-82.71K
-0.64%
Dec 31, 2024
Norges Bank Investment Management (NBIM)
12.62M
2.53%
+276.47K
+2.24%
Dec 31, 2024
UBS Fund Management (Switzerland) AG
11.93M
2.39%
+211.04K
+1.80%
Dec 31, 2024
Zürcher Kantonalbank (Asset Management)
8.93M
1.79%
+306.70K
+3.56%
Dec 31, 2024
Harding Loevner LP
8.48M
1.7%
-795.85K
-8.58%
Dec 31, 2024
查看更多
持股ETF
更新時間: 4月6日 週日
更新時間: 4月6日 週日
機構名稱
佔比
Global X Aging Population ETF
3.13%
Franklin FTSE Switzerland ETF
2.92%
iShares MSCI Switzerland ETF
2.87%
First Trust Switzerland Alphadex Fund
2.55%
Running Oak Efficient Growth ETF
1.99%
BNY Mellon Women's Opportunities ETF
1.96%
Global X S&P Catholic Values Developed ex-US ETF
1.43%
First Trust Indxx Medical Devices ETF
1.28%
iShares Global Healthcare ETF
0.62%
Wahed Dow Jones Islamic World ETF
0.57%
查看更多
Global X Aging Population ETF
佔比3.13%
Franklin FTSE Switzerland ETF
佔比2.92%
iShares MSCI Switzerland ETF
佔比2.87%
First Trust Switzerland Alphadex Fund
佔比2.55%
Running Oak Efficient Growth ETF
佔比1.99%
BNY Mellon Women's Opportunities ETF
佔比1.96%
Global X S&P Catholic Values Developed ex-US ETF
佔比1.43%
First Trust Indxx Medical Devices ETF
佔比1.28%
iShares Global Healthcare ETF
佔比0.62%
Wahed Dow Jones Islamic World ETF
佔比0.57%
分紅派息
近5年累計派現
400.00M
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
Mar 01, 2022
ALC.NB Final Cash Dividend of gross CHF 0.2 paid on May 05, 2022 going ex on Apr 29, 2022
May 04, 2022
May 05, 2022
May 03, 2022
Feb 24, 2021
ALC.NB Final Cash Dividend of gross CHF 0.1 paid on May 06, 2021 going ex on May 04, 2021
May 05, 2021
May 06, 2021
May 04, 2021
拆合股
公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據